Enhanced CAV1 expression has previously been associated with neuroprotection (Sawada et al., 2019) and reduced CAV1 expression has been associated with risk for ALS (Cooper-Knock et al., 2020). This evidence concerns the gene CAV1 and amyotrophic lateral sclerosis.